Bromfenac Sodium Solution/ Drops
Product Images NDC 46708-583

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bromfenac Sodium (NDC 46708-583). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bromfenac-bottle-ltd (Bromfenac Bottle Ltd)

This is a product description for Bromfenac Ophthalmic Solution 0.07%, manufactured by Alembic Pharmaceuticals Limited in Gujarat, India. It is recommended for topical application in the eye, with a usual dosage outlined in the package insert. The product should be stored between 15°C to 25°C (59°F to 77°F). The lot number and expiry date are provided as well.*

FDA Label Image

Bromfenac-carton-ltd (Bromfenac Carton Ltd)

This is a description of Bromfenac Ophthalmic Solution, an eye care product manufactured by Alembic Pharmaceuticals Limited in Gujarat, India. It is a sterile solution for topical application in the eye, used once daily. The solution includes active ingredient bromfenac sodium hydrate and a preservative called benzalkonium chloride. It is advised to instill one drop into the affected eye starting one day before surgery, continuing through the day of surgery, and for the first 14 days post-surgery. The product should be stored between 15° to 25°C.*

FDA Label Image

Bromfenac-structure (Bromfenac Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.